PCC has initiated a new and exciting project with strategy consulting and market intelligence specialists DeciBio, which has now successfully completed phase 1, culminating in a productive and insightful face-to-face workshop at ASCO in June.  The project aims to reveal insights into the adoption of liquid biopsy testing and find solutions for under-served populations. Read more about this project here and look out for the publication of phase 2 findings later this year.